*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Varenicline Tartrate is a nicotinic acetylcholine receptor partial agonist used primarily in smoking cessation therapy. It is synthesized via multi-step organic chemistry with high purity standards. <strong>Molecular Formula</strong>: C<sub>10</sub>H<sub>15</sub>N<sub>3</sub>O·C<sub>4</sub>H<sub>6</sub>O<sub>6</sub>; <strong>CAS No.</strong>: 129687-96-3.</p>
<h3>Application</h3>
<ul>
<li>Pharmaceutical manufacturing for prescription cessation drugs.</li>
<li>R&D of novel nicotine replacement therapies.</li>
<li>Quality control laboratories for active pharmaceutical ingredients.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated for patients with severe renal impairment without dosage adjustment. Store below 25°C in dry, light-resistant containers. Handle with appropriate PPE to avoid inhalation or skin contact during processing.</p>